Idiopathic pulmonary fibrosis (IPF) is characterized by a dominant pattern of reticular opacities and honeycombing, predominantly in the subpleural regions of the lower lobes. Ground-glass opacities and traction bronchiectasis may also be seen. The distribution demonstrates an apicobasal gradient. Nonspecific interstitial pneumonitis (NSIP) most commonly demonstrates a dominant ground-glass opacity pattern, distributed bilaterally and more prominent in the lower lobes without an apicobasal gradient. Cryptogenic organizing pneumonia (COP) appears as patches of consolidation and ground-glass opacity in the peripheral and subpleural regions of the middle and lower lung zones.
2. Definition
A heterogeneous group of conditions
that affect the connective tissue
interstitium as well as the alveolar
epithelium and capillary endothelium
of the lungs.
Harrison
3. Previously called ILD
• Involves not only interstitium
• But all components of lung parenchyma
• Hence renamed as DPLD
Oxford | Cecil | Davidson
4. DPLD is an “Umbrella” Term
• >200 disease entities
• Varying aetiologies & pathogeneses (infections &
malignancies not included, by convention)
• Clinical, spirometric, imaging & histologic features
are overlapping
Nadel
5. A Diagnostic Challenge
• Clinical, spirometric, imaging & histologic features
are overlapping
• 10% are normal on CXR & PFT
• HRCT 90% sensitive
Nadel
6. Role of Radiology
• About 10 diseases account for 90% cases
• Primary goal is to distinguish treatable
from untreatable disease
RA | Nadel
7. DPLDs are Disease for
Everyone |
Radiologist Pulmonologist
Rheumatology Intensive /
Palliative Care
Geriatrics
Occupational
HealthEnvironmental
Health
Oncology
Public Health
66. CT LungHoneycombing : Differentials
• Represents irreversible /
end-stage destruction
• Primarily a feature of
IPF
67. Steps of Evaluation by Imaging
1. Dominant pattern
2. Location : Centrilobular / perilymphatic / random
3. Distribution : Upper or lower; Central or peripheral; Unilateral or
bilateral; Symmetic or asymmetric
4. Other findings : Effusion, lymph nodes, etc
• C/F and other investigations
68. • >200 diseases
• About 10 diseases cover 90% of cases
• Characteristic HRCT features
• Aim is to detect treatable disease ILD Atlas | RA
73. Idiopathic Pulmonary Fibrosis Tubaikh
• Dominant pattern : Reticular & honeycombing
• Additional pattern : Ground-glass & traction bronchiectasis
• Distribution : Distinctly subpleural
• Location : Basal + peripheral, reducing towards apex (apicobasal
gradient)
• No identifiable cause of fibrosis
74. Idiopathic Pulmonary Fibrosis Tubaikh
• Dominant pattern : Reticular & honeycombing
• Additional pattern : Ground-glass & traction bronchiectasis
• Distribution : Distinctly subpleural
• Location : Basal + peripheral, reducing towards apex (apicobasal
gradient)
• No identifiable cause of fibrosis
75. Idiopathic Pulmonary Fibrosis Tubaikh
• Ground-glass opacities represent pre-fibrotic change, i.e. treatable
(steroid-responsive)
• Honeycombed areas represent established / advanced fibrosis, i.e.
irreversible / end-stage parenchymal destruction
76. Idiopathic Pulmonary Fibrosis Tubaikh
• Ground-glass opacities represent pre-fibrotic change, i.e. treatable
(steroid-responsive)
• Extensive ground-glass opacities / ground-glass opacities other than
adjacent to fibrotic areas suggest alternative diagnosis
77. Idiopathic Pulmonary Fibrosis Tubaikh
• Ground-glass opacities represent pre-fibrotic change, i.e. treatable
(steroid-responsive)
• Extensive ground-glass opacities / ground-glass opacities other than
adjacent to fibrotic areas suggest alternative diagnosis
• Absence of apicobasal gradient, relative sparing of subpleural zone
suggest alternative diagnosis
79. Idiopathic Pulmonary Fibrosis Tubaikh
• Mild mediastinal lymphadenopathy present in 70% cases
• L/N > 15 mm or >2 nodal stations suggests associated malignancy
80. Idiopathic Pulmonary Fibrosis Tubaikh
• Mild mediastinal lymphadenopathy present in 70% cases
• L/N > 15 mm or >2 nodal stations suggests associated malignancy
• Bronchogenic carcinoma is 10-20 times more common in IPF
always look for a mass
81. Idiopathic Pulmonary Fibrosis Tubaikh
• Mild mediastinal lymphadenopathy present in 70% cases
• L/N > 15 mm or >2 nodal stations suggests associated malignancy
• Bronchogenic carcinoma is 10-20 times more common in IPF
always look for a mass
• Pleural effusion also suggests malignancy (5% false +ve)
115. Langerhans Cell HistiocytosisMurray & Nadel
• Centrilobular nodules
and cysts
• Most prominent in the
upper lobes
• Occasionally
accompanied by
pneumothorax
116. Langerhans Cell HistiocytosisMurray & Nadel
• Centrilobular nodules
and cysts
• Most prominent in the
upper lobes
• Occasionally
accompanied by
pneumothorax
117. Langerhans Cell HistiocytosisMurray & Nadel
• Centrilobular nodules
and cysts
• Most prominent in the
upper lobes
• Occasionally
accompanied by
pneumothorax
119. Murray & NadelSarcoidosis
• hilar & mediastinal L/N
• nodules deposited along
bronchovascular bundles
and interlobular septa
• air space filling due to
lymphocyte-macrophage
alveolitis
• linear densities secondary
to fibrotic scarring
124. Other Modalities
• Gallium-67
• Selectively accumulates in
areas of infection,
inflammation, and neoplasm
• Assessment of the extent of
sarcoidosis
ILD Atlas
ILD represent a heterogeneous group of conditions that involve the parenchyma of the lung—the alveoli, the alveolar epithelium, the capillary endothelium, and the spaces between those structures—as well as the perivascular and lymphatic tissues.
this heterogeneous group are classified together because of similar clinical, roentgenographic, physiologic, or pathologic manifestations (H-18).
ILD represent a heterogeneous group of conditions that involve the parenchyma of the lung—the alveoli, the alveolar epithelium, the capillary endothelium, and the spaces between those structures—as well as the perivascular and lymphatic tissues.
this heterogeneous group are classified together because of similar clinical, roentgenographic, physiologic, or pathologic manifestations (H-18).
ILD represent a heterogeneous group of conditions that involve the parenchyma of the lung—the alveoli, the alveolar epithelium, the capillary endothelium, and the spaces between those structures—as well as the perivascular and lymphatic tissues.
this heterogeneous group are classified together because of similar clinical, roentgenographic, physiologic, or pathologic manifestations (H-18).
ILD represent a heterogeneous group of conditions that involve the parenchyma of the lung—the alveoli, the alveolar epithelium, the capillary endothelium, and the spaces between those structures—as well as the perivascular and lymphatic tissues.
this heterogeneous group are classified together because of similar clinical, roentgenographic, physiologic, or pathologic manifestations (H-18).
ILD represent a heterogeneous group of conditions that involve the parenchyma of the lung—the alveoli, the alveolar epithelium, the capillary endothelium, and the spaces between those structures—as well as the perivascular and lymphatic tissues.
this heterogeneous group are classified together because of similar clinical, roentgenographic, physiologic, or pathologic manifestations (H-18).
ILD represent a heterogeneous group of conditions that involve the parenchyma of the lung—the alveoli, the alveolar epithelium, the capillary endothelium, and the spaces between those structures—as well as the perivascular and lymphatic tissues.
this heterogeneous group are classified together because of similar clinical, roentgenographic, physiologic, or pathologic manifestations (H-18).
ILD represent a heterogeneous group of conditions that involve the parenchyma of the lung—the alveoli, the alveolar epithelium, the capillary endothelium, and the spaces between those structures—as well as the perivascular and lymphatic tissues.
this heterogeneous group are classified together because of similar clinical, roentgenographic, physiologic, or pathologic manifestations (H-18).
Distal to terminal bronchioles, i.e. take part in gas exchange
secondary pulmonary lobule or parts of it can be seen by CT, even when lung is normal. That is why the secondary pulmonary lobule is the ideal unit of subsegmental lung organisation with which the CT and pathologic abnormality can be correlated. At the same time, HRCT is the only radiological method that can visualize details of the secondary pul-monary lobule, which is why it is the most useful imaging modality for ILD.
septa penetrate deeply as incomplete partitions from the subpleural space between lung segments and subsegments
but also between secondary pulmonary lobules and Acini . components of sec lob are not separated by septa but only supported by fibrous strands.
septa penetrate deeply as incomplete partitions from the subpleural space between lung segments and subsegments
but also between secondary pulmonary lobules and Acini . components of sec lob are not separated by septa but only supported by fibrous strands.
D/D by pattern of interstitial involvement
* Parenchymal : Elastic & collagen fibres that provide a supporting framework for the alveolar capillaries
* peripheral connective tissue includes the sub-pleural space and the lung septa that penetrate deeply as incomplete partitions from the subpleural space into the lung not only between lung segments and subsegments but also between secondary pulmonary lobules and acini (Weibel1979). So the pleura is in anatomic continuity with the different lung septa.
* AXIAL : originates at the hilum, surrounds the bronchovascular structures and extends peripherally upto at the centre of the acini
D/D by pattern of interstitial involvement
* Parenchymal : Elastic & collagen fibres that provide a supporting framework for the alveolar capillaries
* peripheral connective tissue includes the sub-pleural space and the lung septa that penetrate deeply as incomplete partitions from the subpleural space into the lung not only between lung segments and subsegments but also between secondary pulmonary lobules and acini (Weibel1979). So the pleura is in anatomic continuity with the different lung septa.
* AXIAL : originates at the hilum, surrounds the bronchovascular structures and extends peripherally upto at the centre of the acini
Identification of these patterns is an important step in the evaluation of HRCT chest, followed by consideration of the location of involvement and patient data (ct lung)
Also known Acinar nodules (dr swajal)
may near centre of lobule, near interlobular septa / parenchyma in between, also in relation to pleura and arterial branches but have no consistent or predominant relationship with any of these structures.
may near centre of lobule, near interlobular septa / parenchyma in between, also in relation to pleura and arterial branches but have no consistent or predominant relationship with any of these structures.